Quantcast

Latest ADHD Stories

2014-10-30 12:29:59

MONTREAL, Oct. 30, 2014 /CNW Telbec/ - Shire Canada Inc. is pleased to announce the winners of the second edition of the Shire Canada ADHD Scholarship Program. The five deserving recipients were nominated following the review and evaluation of scholarship applications by an independent panel of judges comprised of six Canadian ADHD experts. The 2014 winners of the Shire Canada ADHD Scholarship Program are: -- Shelby Running Rabbit (Alberta); -- Jenna Vandal (Manitoba); --...

2014-10-21 08:34:41

LOS ANGELES, Oct. 21, 2014 /PRNewswire/ -- An automated EEG biofeedback system works just as well as a clinician-run system in helping reduce attention deficits in those with substance use disorders, according to an independent joint study from researchers at UCLA and UNC Wilmington. Photo - http://photos.prnewswire.com/prnh/20141020/153183 The finding means that addiction treatment centers now have an easier and more affordable way to help clients with issues such as ADHD learn...

2014-10-16 08:31:37

TORONTO, Oct. 16, 2014 /PRNewswire/ - Highland Therapeutics Inc. ("Highland"), a pharmaceutical company, today announced it has completed a US$25 million offering of Class A Common Shares. The financing was led by a private equity partner that is committed to Highland's long-term success. The funds raised will provide, among other things, the necessary resources for Highland, through its wholly owned subsidiary Ironshore Pharmaceuticals & Development, Inc. to (i) complete the...

2014-10-14 16:28:02

North Carolina technical assistant wins a free space makeover PHILADELPHIA, Oct. 14, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) today announced the winners of the Organize Your Stuff contest, which was designed to help adults organize their space and reduce clutter. Sydney Bloom, 28, from Charlotte, NC was chosen as the grand prize winner after submitting a picture of her craft room and the reason she needed help organizing it. To help Sydney achieve her organizational goals,...

2014-10-09 23:06:27

Prakash Masand, MD, who is a former consulting professor of psychiatry and behavioral sciences at Duke University, a New York City psychiatrist, and the founder and CEO of Global Medical Education (GME), says that ADHD is not just bad behavior, but a serious psychiatric illness which can have devastating consequences to individuals, families, and society as a whole. As part of Mental Illness Week, he offers the facts below about ADHD in an effort to help shed light on this debilitating...

2014-10-09 04:20:56

PHILADELPHIA, October 9, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that it has received further guidance from the U.S. Food and Drug Administration (FDA) on the regulatory path for SHP 465 (triple-bead mixed amphetamine salts MAS), an investigational oral stimulant medication being evaluated as a potential treatment for Attention-Deficit/Hyperactivity Disorder (ADHD) in adults. On April 25, 2014, in written correspondence, the FDA responded to...

2014-10-06 12:29:08

TORONTO, Oct. 6, 2014 /PRNewswire/ - Highland Therapeutics Inc. ("Highland"), today announced that Phase II data generated by the Company's principal operating subsidiary, Ironshore Pharmaceuticals & Development, Inc. ("Ironshore"), will be presented at the American Academy of Child & Adolescent Psychiatry (AACAP) Annual Meeting, which is being held October 20(th) to 25(th) in San Diego, CA. Data from the HLD-200 (methylphenidate) Phase II study, The Single Dose...

2014-09-24 12:28:59

TORONTO, Sept. 24, 2014 /PRNewswire/ - Highland Therapeutics Inc. ("Highland"), today announced the appointment of Dr. Floyd R. Sallee as Chief Medical Officer of Ironshore Pharmaceuticals & Development, Inc. ("Ironshore"), Highland's wholly owned principal operating subsidiary. As an expert in pediatric psychopharmacology, Dr. Sallee has been an important adviser and consultant to Ironshore on the development of the Company's investigational drug products, HLD-100 (amphetamine)...

2014-09-23 23:06:05

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it had reached an exclusive development and licensing agreement with privately held biopharmaceutical company, Cingulate Therapeutics (CTx), to support the development of a series of new prescription pharmaceutical products for the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) using...

ADHD
2014-09-17 03:00:27

Kara Gavin, University of Michigan Health System Brain networks to handle internal & external tasks mature more slowly in ADHD A peek inside the brains of more than 750 children and teens reveals a key difference in brain architecture between those with attention deficit hyperactivity disorder (ADHD) and those without. Kids and teens with ADHD, a new study finds, lag behind others of the same age in how quickly their brains form connections within, and between, key brain...


Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related